Company profile
Ziarco Pharma Ltd
403 Forbidden
Ziarco Pharma Ltd is a UK company with status active founded in 2012.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Move Registers To Sail Company With New Address
AddressAD03 | Transaction MzQzOTkxMjA3MWFkaXF6a2N4 | Paper/PDF filed
Published 30 Oct 2024 07:17
Change Sail Address Company With New Address
AddressAD02 | Transaction MzQzOTkxMjA3MGFkaXF6a2N4 | Paper/PDF filed
Published 29 Oct 2024 07:13
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzOTA0OTY5OWFkaXF6a2N4 | Paper/PDF filed
Published 30 Oct 2024 12:34
Resolution
ResolutionRESOLUTIONS | Transaction WURERzBWSVlhZGlxemtjeA | Paper/PDF filed
Published 18 Oct 2024 12:53
Liquidation Voluntary Declaration Of Solvency
InsolvencyLIQ01 | Transaction MzQzOTA0OTU5NGFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 01:58
Liquidation Voluntary Appointment Of Liquidator
Insolvency600 | Transaction MzQzOTA0OTQwMmFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 01:58
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzI1MjIyNDg3MmFkaXF6a2N4
Published 30 Oct 2024 12:34
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzI1MjIzMzcyM2FkaXF6a2N4
Published 30 Oct 2024 12:34
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzE2NzIwODQ1N2FkaXF6a2N4
Published 30 Oct 2024 12:34
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzExMTM1NTUzMWFkaXF6a2N4
Published 30 Oct 2024 12:34
Change Registered Office Address Company With Date Old Address
AddressAD01 | Transaction MzA2OTc2NTgwM2FkaXF6a2N4 | Paper/PDF filed
Published 30 Oct 2024 12:34
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
PoC clinical study of ZPL-3893787 on pruritus and inflammation in atopic dermatitis
1 Oct 2014 to 31 Jul 2016
Ziarco Pharma Limited, of Canterbury, Kent is developing ZPL-3893787, a novel oral treatment for the itch and inflammation associated with chronic pruritus (CP) - defined as an undesirable condition that stimulates scratching, persisting for at least 6 weeks. It affects all ages, from young infants through to the elderly. CP can result in disturbed/lack o...